ReviewMolecular medicine (Cambridge, Mass.)2026
Diet-stress interactions in gut barrier dysfunction and metabolic inflammation.
Review in Molecular medicine (Cambridge, Mass.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundThe intestinal barrier is a dynamic host-microbe interface that contributes to metabolic homeostasis. Chronic psychological stress and adverse dietary patterns can each disturb microbiota, mucus, junctional, and inflammatory processes. This review evaluates the evidence for convergence of diet- and stress-responsive pathways at the intestinal barrier and their possible relevance to metabolic inflammation. MAIN BODY: Activation of the hypothalamic-pituitary-adrenal (HPA) and sympatho-adrenomedullary axes, together with adverse dietary exposures, converges on the gut microbiota and epithelial barrier. Stress-related corticotropin-releasing hormone/mast-cell signalling, glucocorticoids, and catecholamines can remodel mucus and tight junctions, while high-fat, Western-style, ultra-processed, or prolonged substrate-restricted diets reduce butyrogenic support and may shift bile-acid metabolism toward barrier-disruptive secondary bile acids. The resulting mucus erosion and tight-junction remodelling, including reduced occludin/ZO-1 and increased pore-forming claudin-2, increase permeability and facilitate lipopolysaccharide translocation. LPS-TLR4-NF-κB signalling provides inflammatory priming and can converge with diet- and stress-related danger signals on the NLRP3 inflammasome, promoting IL-1β, TNF-α, and IL-6 release. These pathways plausibly contribute to obesity, insulin resistance, type 2 diabetes, and metabolic dysfunction-associated steatotic liver disease, although direct human evidence for a true diet × stress barrier interaction remains limited.
conclusionPreclinical studies provide mechanistic support for overlapping diet- and stress-responsive barrier pathways, and acute human stress studies provide functional permeability evidence. Human dietary evidence is more often indirect, and direct factorial studies of diet × stress effects on barrier function are largely absent. The proposed framework should therefore be treated as a testable synthesis rather than an established causal model.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.